HEPATOCELLULAR CARCINOMA IN PAKISTAN: WHERE DO WE STAND?

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

BUTT AMNA SUBHAN; ABBAS ZAIGHAM; JAFRI WASIM

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Hepatitis Monthly Year:2012 | Volume:12 | Issue:10 Page(s): 0-0

Download Full-Text

View:

298

Download:

232

Cites:

Information Journal Paper

Title

HEPATOCELLULAR CARCINOMA IN PAKISTAN: WHERE DO WE STAND?

Author(s)

BUTT AMNA SUBHAN | ABBAS ZAIGHAM | JAFRI WASIM | Issue Writer Certificate

Keywords

CARCINOMA

HEPATOCELLULAR

PAKISTAN

HEPATITIS C

Abstract

Context: From the 1970s till the mid 1990s, hepatitis B was the most common etiological factor for HEPATOCELLULAR CARCINOMA (HCC) in PAKISTAN. Afterwards, a shift in HCC etiology was observed with a steady rise in HEPATITIS C virus (HCV) related HCC cases. HCV-3a, which is the most prevalent genotype, is also most frequent in HCV related HCC. There was an increase in the proportion of non-B non-C (NBNC) HCC cases as well, which might be attributed to an increase in non-alcoholic fatty liver disease.Evidence Acquisition: The age-standardized rate for HCC is 7.64/100 000 in males and 2.8/100 000 in females. Male to female ratio is 3.6:1. Usual age of presentation is in the fifth and sixth decade. Most patients present with advanced disease, as they are not in a regular surveillance program. This is more so for patients with NBNC chronic liver disease. As many sonologists in PAKISTAN are practicing without sufficient training to pick up early lesions, alpha-fetoprotein is still recommended to compliment ultrasound in the surveillance of HCC.Results: Majority of HCC patients present with nonresectable disease. Interventions such as transarterial chemoembolization, radiofrequency ablation, resection and chemotherapy including sorafenib are available in selected centers. PAKISTAN appears to be in an area of intermediate endemicity for HCC. There is a need for population based epidemiological studies to estimate the exact disease burden.Conclusions: Measures to prevent the spread of HEPATITIS C and B can slow down the epidemic rise in the incidence of HCC in the coming decades. There is a need to implement a proper surveillance program to identify HCC cases at an early stage.

Cites

No record.

References

No record.

Cite

APA: Copy

BUTT, AMNA SUBHAN, ABBAS, ZAIGHAM, & JAFRI, WASIM. (2012). HEPATOCELLULAR CARCINOMA IN PAKISTAN: WHERE DO WE STAND?. HEPATITIS MONTHLY, 12(10), 0-0. SID. https://sid.ir/paper/306811/en

Vancouver: Copy

BUTT AMNA SUBHAN, ABBAS ZAIGHAM, JAFRI WASIM. HEPATOCELLULAR CARCINOMA IN PAKISTAN: WHERE DO WE STAND?. HEPATITIS MONTHLY[Internet]. 2012;12(10):0-0. Available from: https://sid.ir/paper/306811/en

IEEE: Copy

AMNA SUBHAN BUTT, ZAIGHAM ABBAS, and WASIM JAFRI, “HEPATOCELLULAR CARCINOMA IN PAKISTAN: WHERE DO WE STAND?,” HEPATITIS MONTHLY, vol. 12, no. 10, pp. 0–0, 2012, [Online]. Available: https://sid.ir/paper/306811/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops